Sound Health Solutions Inc. (SHSO) News

CARLSBAD, Calif., Oct. 19 /PRNewswire-FirstCall/ -- iVOW, Inc. (Nasdaq: IVOWD), today announced that company executives are exhibiting at the American College of Surgeons' 91st Annual Clinical Congress being held this week in San Francisco, CA. At the Clinical Congress, iVOW will discuss its updated portfolio of management and consulting services for morbid obesity focused disease management programs. iVOW's Clinical Advisory Group of Drs. Frances Gough, Neil Hutcher, Peter LePort, Lou Martin, Karl Miller and Mitchell Roslin will be convening at the ACS meeting to provide ongoing assistance to iVOW's evolution of its clinical programs, practice efficiency processes, products and strategic positioning.

The American College of Surgeons (ACS) is a scientific and educational association of surgeons that was founded in 1913 to improve the quality of care for the surgical patient by setting high standards for surgical education and practice. The College currently has more than 64,000 Fellows, including more than 3,700 Fellows in other countries, making it the largest organization of surgeons in the world. There are presently more than 5,000 Associate Fellows. The ACS Clinical Congress features 39 postgraduate courses, more than 300 hours of general and specialty sessions, and hundreds of scientific exhibits and technical exhibits from a wide variety of companies.

Earlier this month, IVOW executives conducted a similar exhibit at the National Association of Health Services Executives' 20th Annual Educational Conference Business Meeting and Exhibition. The National Association of Health Services Executives (NAHSE) is a non-profit association of Black health care executives founded in 1968 for the purpose of promoting the advancement and development of Black health care leaders, and elevating the quality of health care services rendered to minority and underserved communities. NAHSE's educational conferences provide a forum for members to learn new skills and exchange experiences and ideas about healthcare administration issues that will promote improved job performance.

Dr. Michael Owens, President and CEO of iVOW, said, 'The ACS and NAHSE meetings provide excellent opportunities for iVOW to present our organizational capability, strategic partnerships and products to a large audience of potential clients. We are making good progress on raising awareness for our unique outsourced services that can help bariatric surgery programs achieve and maintain a 'Center of Excellence' designation that we believe is essential for success in the current reimbursement environment. We are optimistic that our highly focused marketing efforts will attract additional clients to IVOW in the months ahead.'

iVOW

Our business is focused exclusively on the disease state management of chronic and morbid obesity. We provide program management, operational consulting and clinical training services to physicians and hospitals involved in the medical and surgical treatment of morbidly obese patients. We also provide specialized vitamins to patients who have undergone obesity surgery. Our corporate website is www.ivow.com; information on our nutritional supplements for post-surgical gastric bypass patients may be found on www.vistavitamins.com. iVOW is the new corporate name of Vista Medical Technologies, Inc. iVOW is traded on the NASDAQ Capital Market under the stock symbol IVOWD.

Forward Looking Statements

This news release may contain forward-looking statements concerning the business and products of iVOW. Actual results may differ materially depending on a number of risk factors, including, but not limited to the following: our ability to penetrate the market for obesity surgery management services; customer acceptance of our products and services; decisions by Medicare and carriers to provide coverage for bariatric surgical procedures; uncertainties related to our healthcare services business model; and our efforts to maintain compliance with the continued listing requirements of the Nasdaq SmallCap Market. Other risks inherent in our business are described in our Securities and Exchange Commission filings, including our Annual Report on Form 10-K for the year ended December 31, 2004, as amended, and our most recent quarterly report on form 10-Q. We undertake no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

     AT iVOW:                            AT FINANCIAL RELATIONS BOARD:

     Michael H. Owens,MD,MPH,FACPE,CPE   Tony Rossi
     President & CEO                     Media Contact
     mowens@ivow.com                     trossi@financialrelationsboard.com
     (760) 603-9120                      (310) 854-8317

SOURCE iVOW, Inc.